Dermatology NewsVitamin D3 supplementation beat placebo in atopic dermatitis trialApril 29, 2017Atopic Dermatitis
Severe Refractory Atopic Dermatitis With Elevated Serum IgE Treated With OmalizumabApril 20, 2017Atopic Dermatitis
Dermatology NewsDupilumab approval marks the first targeted treatment for ADApril 17, 2017Atopic Dermatitis
Dermatology NewsInpatient cost of atopic dermatitis called ‘substantial’April 5, 2017Atopic Dermatitis
Dermatology NewsDupilumab: FDA approves first biologic for atopic dermatitisMarch 28, 2017Atopic Dermatitis
Dermatology NewsDupilumab improved eczema scores in children in open label trialMarch 20, 2017Atopic DermatitisPediatrics
Dermatology NewsHow will crisaborole for atopic dermatitis fit into clinical practice?March 17, 2017Atopic DermatitisPediatrics
Dermatology NewsNew 52-week EASI, pruritus data strengthen case for dupilumab in adult atopic dermatitisMarch 9, 2017Atopic Dermatitis
Dermatology NewsWhen atopic dermatitis is really contact dermatitisMarch 6, 2017Contact DermatitisAtopic Dermatitis
Dermatology NewsLate-breaking research presented March 4-5 at AAD meetingFebruary 27, 2017Atopic Dermatitis
Dermatology NewsTips for taming atopic dermatitis and managing expectationsFebruary 23, 2017Atopic Dermatitis
Dermatology NewsRituximab is dramatically effective in IgG4-related diseaseFebruary 10, 2017Rare DiseasesAutoimmune DiseasesAtopic Dermatitis
